A detailed history of Schulhoff & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Schulhoff & CO Inc holds 4,860 shares of LLY stock, worth $3.87 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares
4,860
Previous 4,880 0.41%
Holding current value
$3.87 Million
Previous $4.42 Million 2.56%
% of portfolio
1.94%
Previous 2.14%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$772.14 - $960.02 $15,442 - $19,200
-20 Reduced 0.41%
4,860 $4.31 Million
Q1 2024

May 01, 2024

SELL
$592.2 - $792.28 $118,440 - $158,456
-200 Reduced 3.94%
4,880 $3.8 Million
Q4 2023

Feb 07, 2024

SELL
$525.19 - $619.13 $15,755 - $18,573
-30 Reduced 0.59%
5,080 $2.96 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $28,255 - $38,954
-65 Reduced 1.26%
5,110 $2.74 Million
Q3 2021

Nov 08, 2021

BUY
$221.6 - $272.71 $11,080 - $13,635
50 Added 0.98%
5,175 $1.2 Million
Q2 2021

Aug 03, 2021

SELL
$180.55 - $233.54 $23,471 - $30,360
-130 Reduced 2.47%
5,125 $1.18 Million
Q1 2021

Apr 30, 2021

SELL
$164.32 - $212.72 $101,878 - $131,886
-620 Reduced 10.55%
5,255 $981,000
Q4 2020

Feb 08, 2021

SELL
$130.46 - $172.63 $65,230 - $86,315
-500 Reduced 7.84%
5,875 $991,000
Q2 2020

Jul 29, 2020

SELL
$136.42 - $164.18 $30,694 - $36,940
-225 Reduced 3.41%
6,375 $1.05 Million
Q3 2019

Nov 01, 2019

SELL
$106.79 - $116.16 $53,395 - $58,080
-500 Reduced 7.04%
6,600 $738,000
Q1 2019

Apr 24, 2019

BUY
$111.31 - $131.02 $19,479 - $22,928
175 Added 2.53%
7,100 $921,000
Q4 2018

Feb 07, 2019

SELL
$105.9 - $118.64 $23,827 - $26,694
-225 Reduced 3.15%
6,925 $801,000
Q2 2018

Aug 03, 2018

SELL
$75.7 - $86.88 $158,970 - $182,448
-2,100 Reduced 22.7%
7,150 $610,000
Q3 2017

Oct 25, 2017

BUY
$77.07 - $85.54 $3,853 - $4,277
50 Added 0.54%
9,250 $791,000
Q2 2017

Aug 08, 2017

BUY
N/A
9,200
9,200 $757,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Schulhoff & CO Inc Portfolio

Follow Schulhoff & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schulhoff & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schulhoff & CO Inc with notifications on news.